Format
Deal Terms Analysis
2025 Working Capital Purchase Price Adjustment Study
Deal Terms Analysis
Life Sciences
Bio/Pharma M&A: Earnout Achievement Insights
Deal Terms Analysis
M&A Deal Terms: Three Trends to Watch in 2025
Deal Terms Analysis
2024 Trends in M&A Indemnification Claims and Earnouts
Deal Terms Analysis
Lower Middle Market M&A Deals: What Makes Them Different?
Deal Terms Analysis
2024 M&A Deal Terms Special Report: Lower Middle-Market Deals
Deal Terms Analysis
2024 M&A Claims Insights Report
Indemnification
Deal Terms Analysis
2024 RWI Highlights: Effect of Reps and Warranties Insurance on M&A Deal Terms
Deal Terms Analysis
2024 M&A Deal Terms: Highlights for M&A Advisors
Deal Terms Analysis
Indemnification
Deal Terms for M&A Escrows - Statistics and Key Findings
Deal Terms Analysis
2024 M&A Deal Terms Study
Deal Terms Analysis
2024 M&A Working Capital PPA Study
Deal Terms Analysis
M&A Earnouts: Be Prepared for 2024
Shareholder Representation
Deal Terms Analysis
M&A Purchase Price Adjustments Are Common Yet Complex
Deal Terms Analysis
Valuation Disconnects Driving a Spike in Earnouts in M&A
Deal Terms Analysis
Lower Middle-Market Mergers & Acquisitions Deals Report
Deal Terms Analysis
Life Sciences
2023 SRS Acquiom Life Sciences M&A Study
Deal Terms Analysis
2023 M&A Deal Terms and Trends for Private Equity Buyers
Deal Terms Analysis
Technology M&A Deal Terms and Trends
Deal Terms Analysis
Indemnification
Effect of Representations and Warranties Insurance on Deal Terms
Deal Terms Analysis
Private M&A Deal Terms: An SRS Acquiom Quick Guide for M&A Advisors
Deal Terms Analysis
Tools and Tactics for Getting Deals Across the Finish Line
Deal Terms Analysis
2023 M&A Deal Terms Study
Deal Terms Analysis
M&A Trends: PPAs and Claims Activity